Selective and potent morpholinone inhibitors of the MDM2-p53 interaction

被引：0

作者：

Gonzalez, Ana Z. ^{[1
]}

Eksterowics, John ^{[1
]}

Beck, Hilary P. ^{[1
]}

Canon, Jude ^{[4
]}

Chen, Ada ^{[1
]}

Chow, David ^{[1
]}

Duquette, Jason ^{[1
]}

Fox, Brian M. ^{[1
]}

Fu, Jiasheng ^{[1
]}

Houze, Jonathan ^{[1
]}

Jin, Lixia ^{[1
]}

Li, Yihong ^{[1
]}

Li, Zhihong ^{[1
]}

Lo, Mei-Chu ^{[1
]}

Long, Alexander M. ^{[5
]}

McGee, Lawrence R. ^{[1
]}

McIntosh, Joel ^{[1
]}

Oliner, Jonathan D. ^{[4
]}

Osgood, Tao ^{[4
]}

Rew, Yosup ^{[1
]}

Saiki, Anne Y. ^{[4
]}

Shaffer, Paul ^{[5
]}

Wortman, Sarah ^{[2
]}

Yakowek, Peter ^{[5
]}

Yan, Xuelei ^{[1
]}

Ye, Qiuping ^{[3
]}

Yu, Dongyin ^{[4
]}

Zhao, Xiaoning ^{[1
]}

Zhou, Jing ^{[1
]}

Olson, Steven H. ^{[1
]}

Medina, Julio C. ^{[1
]}

Sun, Daqing ^{[1
]}

机构：

[1] Amgen Inc, Dept Therapeut Discovery, San Francisco, CA 94080 USA

[2] Amgen Inc, Pharmaceut, San Francisco, CA 94080 USA

[3] Amgen Inc, Dept Therapeut Discovery, Thousand Oaks, CA 91320 USA

[4] Amgen Inc, Oncol Res, Thousand Oaks, CA 91320 USA

[5] Amgen Inc, Dept Therapeut Discovery, Cambridge, MA 02142 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2013年 / 246卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

页数：1

共 50 条

[31] Isoindolinone-based inhibitors of the MDM2-p53 protein-protein interaction
Hardcastle, IR
Ahmed, SU
Atkins, H
Calvert, AH
Curtin, NJ
Farnie, G
Golding, BT
Griffin, RJ
Guyenne, S
Hutton, C
Källbad, P
Kemp, SJ
Kitching, MS
Newell, DR
Norbedo, S
Northen, JS
Reid, RJ
Saravanan, K
Willems, HMG
Lunec, J
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (05) : 1515 - 1520
[32] Proapoptotic modification of substituted isoindolinones as MDM2-p53 inhibitors
Grigoreva, Tatyana A.
Novikova, Daria S.
Petukhov, Alexey V.
Gureev, Maxim A.
Garabadzhiu, Alexander V.
Melino, Gerry
Barlev, Nickolai A.
Tribulovich, Vyacheslav G.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (23) : 5197 - 5202
[33] POTENT INHIBITION OF HUMAN LIPOSARCOMA GROWTH AND SURVIVAL BY NOVEL MODULATORS OF THE MDM2-P53 INTERACTION
Wagner, A. J.
Zhang, Y. X.
Sicinska, E.
Czaplinski, J. T.
Remillard, S. P.
Demetri, G. D.
Weng, S.
Debussche, L.
ANNALS OF ONCOLOGY, 2013, 24 : 14 - 14
[34] Design, Synthesis and Evaluation of 2,5-Diketopiperazines as Inhibitors of the MDM2-p53 Interaction
Pettersson, Mariell
Quant, Maria
Min, Jaeki
Iconaru, Luigi
Kriwacki, Richard W.
Waddell, M. Brett
Guy, R. Kiplin
Luthman, Kristina
Grotli, Morten
PLOS ONE, 2015, 10 (10):
[35] Structure-Based Design of Potent and Orally Active Isoindolinone Inhibitors of MDM2-p53 Protein-Protein Interaction
Chessari, Gianni
Hardcastle, Ian R.
Ahn, Jong Sook
Anil, Burcu
Anscombe, Elizabeth
Bawn, Ruth H.
Bevan, Luke D.
Blackburn, Timothy J.
Buck, Ildiko
Cano, Celine
Carbain, Benoit
Castro, Juan
Cons, Ben
Cully, Sarah J.
Endicott, Jane A.
Fazal, Lynsey
Golding, Bernard T.
Griffin, Roger J.
Haggerty, Karen
Harnor, Suzannah J.
Hearn, Keisha
Hobson, Stephen
Holvey, Rhian S.
Howard, Steven
Jennings, Claire E.
Johnson, Christopher N.
Lunec, John
Miller, Duncan C.
Newell, David R.
Noble, Martin E. M.
Reeks, Judith
Revill, Charlotte H.
Riedinger, Christiane
St Denis, Jeffrey D.
Tamanini, Emiliano
Thomas, Huw
Thompson, Neil T.
Vinkovic, Mladen
Wedge, Stephen R.
Williams, Pamela A.
Wilsher, Nicola E.
Zhang, Bian
Zhao, Yan
JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (07) : 4071 - 4088
[36] Inhibitors of the MDM2-p53 protein-protein interaction based on an isoindolinone scaffold.
Hardcastle, IR
Ahmed, SU
Barrett, PA
Endicott, JA
Golding, BT
Griffin, RJ
Gruber, J
Hutton, C
Kemp, SJ
Lunec, J
Noble, ME
Riedinger, C
Smyth, LA
CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9053S - 9054S
[37] Structure-based de novo design of novel inhibitors of the MDM2-p53 interaction
Sun, Daqing
Rew, Yosup
De Turiso, Felix Gonzalez Lopez
Bartberger, Michael D.
Beck, Hilary P.
Canon, Jude
Chen, Ada
Chow, David
Deignan, Jeffrey
Fox, Brian M.
Huang, Xin
Jiang, Min
Jiao, Xianyun
Jin, Lixia
Kopecky, David J.
Li, Yihong
Lo, Mei-Chu
Long, Alexander M.
Michelsen, Klaus
Oliner, Jonathan D.
Osgood, Tao
Saiki, Anne Y.
Schneider, Steve
Yakowec, Peter
Yan, Xuelei
Ye, Qiuping
Yu, Dongyin
Zhao, Xiaoning
Zhou, Jing
Olson, Steven H.
Medina, Julio C.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
[38] The MDM2-p53 pathway revisited
Nag, Subhasree
Qin, Jiangjiang
Srivenugopal, Kalkunte S.
Wang, Minghai
Zhang, Ruiwen
JOURNAL OF BIOMEDICAL RESEARCH, 2013, 27 (04): : 254 - 271
[39] MDM2-p53 protein-protein interaction inhibitors: A-ring substituted isoindolinones
Watson, Anna F.
Liu, Junfeng
Bennaceur, Karim
Drummond, Catherine J.
Endicott, Jane A.
Golding, Bernard T.
Griffin, Roger J.
Haggerty, Karen
Lu, Xiaohong
McDonnell, James M.
Newell, David R.
Noble, Martin E. M.
Revill, Charlotte H.
Riedinger, Christiane
Xu, Qing
Zhao, Yan
Lunec, John
Hardcastle, Ian R.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (19) : 5916 - 5919
[40] Molecular dynamics simulations studies and free energy analysis on inhibitors of MDM2-p53 interaction
Niu, Rui-Juan
Zheng, Qing-Chuan
Zhang, Ji-Long
Zhang, Hong-Xing
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2013, 46 : 132 - 139

← 1 2 3 4 5 →